Managing the Menopause
Editors:
- Nick PanayNPNick Panay
- Paula BriggsPBPaula Briggs
- Gab KovacsGKGab Kovacs
- 20 August 2015
- book
- Published by Cambridge University Press (CUP)
Abstract
Since the Women's Health Initiative report of 2002, there has been reluctance to provide women with hormone replacement therapy due to a lack of clarity about the potential risks. This book reviews all aspects of the menopause and places the benefits and risks of hormone therapy into perspective. It fully informs the reader regarding the evidence base of all aspects of menopause medicine and can be used either as a reference book to solve specific problems, or as a book to be read cover-to-cover. It will provide the reader with the latest information and as a result encourage confidence in managing menopause related problems. This practical, evidence-based guide is suitable for all health professionals managing the menopause including gynaecologists, sexual and reproductive medicine specialists, general practitioners and trainees in any of the above specialties.Keywords
This publication has 100 references indexed in Scilit:
- Pretreatment anti-Müllerian hormone predicts for loss of ovarian function after chemotherapy for early breast cancerEuropean Journal of Cancer, 2013
- Age-specific probability of live birth with oocyte cryopreservation: an individual patient data meta-analysisFertility and Sterility, 2013
- Hormone replacement therapy after breast cancer: 10 year follow up of the Stockholm randomised trialEuropean Journal of Cancer, 2013
- Unopposed estrogen and estrogen plus progestin menopausal hormone therapy and lung cancer risk in the NIH–AARP Diet and Health Study CohortCancer Causes & Control, 2012
- The time is now for a new approach to primary ovarian insufficiencyFertility and Sterility, 2011
- The association of menstrual and reproductive factors with upper gastrointestinal tract cancers in the NIH‐AARP cohortCancer, 2010
- Estrogen action on bone marrow osteoclast lineage cells of postmenopausal women in vivoOsteoporosis International, 2008
- FRAX™ and the assessment of fracture probability in men and women from the UKOsteoporosis International, 2008
- Effects of Tamoxifen vs Raloxifene on the Risk of Developing Invasive Breast Cancer and Other Disease OutcomesThe NSABP Study of Tamoxifen and Raloxifene (STAR) P-2 TrialJAMA, 2006
- Randomized Trial of Estrogen Plus Progestin for Secondary Prevention of Coronary Heart Disease in Postmenopausal WomenJAMA, 1998